GENZYME CORP Marketable Securities, Equity Securities (Deprecated 2018-01-31)
GENZYME CORP had Marketable Securities, Equity Securities (Deprecated 2018-01-31) of $55.94 million as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Investments
us-gaap:MarketableSecuritiesEquitySecurities · last filed 2011-03-01
- 2010-12-31: Marketable Securities, Equity Securities (Deprecated 2018-01-31) $55.94M.
- 2009-12-31: Marketable Securities, Equity Securities (Deprecated 2018-01-31) $62.22M.
| Period end | Marketable Securities, Equity Securities (Deprecated 2018-01-31) |
|---|---|
| 2010-12-31 | $55.94M 10-K · filed 2011-03-01 |
| 2009-12-31 | $62.22M 10-K · filed 2011-03-01 |